Biologics, with their precision targeting, expand treatment options for a multitude of diseases - from cancer to autoimmune disorders. In 2023 alone, 10 antibody therapeutics received their first ...

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

In a Q&A, an FDA spokesperson discusses efforts to reduce misinformation about biosimilars through education, the agency’s collaboration with global regulators to streamline development, and its work ...

Specialized AI agents combined with precise human-in-the-loop control points create accurate, high-quality regulatory documents up to 94% faster SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ -- Peer AI, a ...

SAN DIEGO, CA, UNITED STATES, July 19, 2024 /EINPresswire.com/ -- Aspen Biosciences, a pioneer in drug discovery software, has completed development of Pipeline’s ...

The novel, end-to-end automated workflow introduces a new method of choice for single-shot mass spectrometry plasma analysis without fractionation The bead-based plasma depletion technology ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases ...